Literature DB >> 3875796

Antigen-dependent increase in cytosolic free calcium in specific human T-lymphocyte clones.

E Nisbet-Brown, R K Cheung, J W Lee, E W Gelfand.   

Abstract

Calcium has been implicated as an intracellular messenger in the cellular response to various external stimuli. Exposure of lymphocytes to various mitogens and lectins results in rapid transmembrane calcium fluxes and increased cytoplasmic calcium concentrations ([Ca2+]i). It is not clear, however, whether the mechanisms by which these non-physiological stimuli activate cells are related to those involved in antigen-specific activation. We have now used antigen-specific T-cell clones to study changes in [Ca2+]i associated with specific activation and show here that these cells respond specifically in the presence of antigen and antigen-presenting cells (APC) with increased [Ca2+]i and that this increased [Ca2+]i shows the same genetic restrictions as are seen in the proliferation assay. The kinetics of the [Ca2+]i response to antigen indicate that antigen undergoes a time-dependent processing step as a prerequisite for recognition by T cells, as has been shown for T-cell proliferative responses, but that the [Ca2+]i response to processed antigen is extremely rapid. The close correlation between changes in [Ca2+]i and cell activation resulting in proliferation suggests that Ca2+ may act as an intracellular messenger in antigen-specific responses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875796     DOI: 10.1038/316545a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  21 in total

1.  Inhibition of T-cell function by FK 506 and cyclosporine is not accompanied by alterations in intracellular calcium.

Authors:  M L Jordan; S Hignet; J Wright; R A Hoffman; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

2.  Induction of a cytoplasmic activator of DNA synthesis in lymphocytes is mediated through a membrane-associated protein kinase.

Authors:  M V Autieri; K L Fresa; F D Coffman; M E Katz; S Cohen
Journal:  Cell Regul       Date:  1990-12

3.  Decreased lymphocyte blastogenesis, IL2 production and NK activity following nifedipine administration to healthy humans.

Authors:  A Morgano; I Pierri; R Stagnaro; M Setti; F Puppo; F Indiveri
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Mitogen-induced oscillations of cytosolic Ca2+ and transmembrane Ca2+ current in human leukemic T cells.

Authors:  R S Lewis; M D Cahalan
Journal:  Cell Regul       Date:  1989-11

Review 5.  Soluble inhibitors of T lymphocyte proliferation: tools for dissecting pathways of T cell activation.

Authors:  J C Reed; P C Nowell
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

6.  The intracellular Ca2+ concentration optimal for T cell activation is quite different after ionomycin or CD3 stimulation.

Authors:  E Donnadieu; G Bismuth; A Trautmann
Journal:  Pflugers Arch       Date:  1995-02       Impact factor: 3.657

7.  Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface.

Authors:  Robert A Ahokas; Kenneth J Warrington; Ivan C Gerling; Yao Sun; Linus A Wodi; Paula A Herring; Li Lu; Syamal K Bhattacharya; Arnold E Postlethwaite; Karl T Weber
Journal:  Circ Res       Date:  2003-10-23       Impact factor: 17.367

8.  Functional heterogeneity of human T cell clones from atopic and non-atopic donors.

Authors:  C A Chambers; B Zimmerman; N Hozumi
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

Review 9.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

10.  Inhibition by SK&F 96365 of Ca2+ current, IL-2 production and activation in T lymphocytes.

Authors:  S C Chung; T V McDonald; P Gardner
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.